RMD
Price
$270.09
Change
+$0.39 (+0.14%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
39.4B
13 days until earnings call
Intraday Buy/Sell Signals
SOLV
Price
$71.45
Change
-$0.11 (-0.15%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
12.39B
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

RMD vs SOLV

Header iconRMD vs SOLV Comparison
Open Charts RMD vs SOLVBanner chart's image
ResMed
Price$270.09
Change+$0.39 (+0.14%)
Volume$9.27K
Capitalization39.4B
Solventum
Price$71.45
Change-$0.11 (-0.15%)
Volume$3.15K
Capitalization12.39B
RMD vs SOLV Comparison Chart in %
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RMD vs. SOLV commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a Hold and SOLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (RMD: $270.00 vs. SOLV: $71.44)
Brand notoriety: RMD and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RMD: 114% vs. SOLV: 73%
Market capitalization -- RMD: $39.4B vs. SOLV: $12.39B
RMD [@Pharmaceuticals: Other] is valued at $39.4B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $12.39B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.8B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 0 FA rating(s) are green whileSOLV’s FA Score has 0 green FA rating(s).

  • RMD’s FA Score: 0 green, 5 red.
  • SOLV’s FA Score: 0 green, 5 red.
According to our system of comparison, RMD is a better buy in the long-term than SOLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 2 TA indicator(s) are bullish while SOLV’s TA Score has 3 bullish TA indicator(s).

  • RMD’s TA Score: 2 bullish, 7 bearish.
  • SOLV’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, SOLV is a better buy in the short-term than RMD.

Price Growth

RMD (@Pharmaceuticals: Other) experienced а -2.84% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -0.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.61%. For the same industry, the average monthly price growth was -0.86%, and the average quarterly price growth was +14.46%.

Reported Earning Dates

RMD is expected to report earnings on Oct 30, 2025.

SOLV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($39.4B) has a higher market cap than SOLV($12.4B). SOLV has higher P/E ratio than RMD: SOLV (32.77) vs RMD (28.36). RMD YTD gains are higher at: 18.833 vs. SOLV (8.144). RMD has higher annual earnings (EBITDA): 1.92B vs. SOLV (1.28B). RMD has more cash in the bank: 1.21B vs. SOLV (492M). RMD has less debt than SOLV: RMD (852M) vs SOLV (7.82B). SOLV has higher revenues than RMD: SOLV (8.39B) vs RMD (5.15B).
RMDSOLVRMD / SOLV
Capitalization39.4B12.4B318%
EBITDA1.92B1.28B151%
Gain YTD18.8338.144231%
P/E Ratio28.3632.7787%
Revenue5.15B8.39B61%
Total Cash1.21B492M246%
Total Debt852M7.82B11%
FUNDAMENTALS RATINGS
RMD: Fundamental Ratings
RMD
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
36
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RMDSOLV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 10 days ago
63%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 7 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EIRL67.790.86
+1.28%
iShares MSCI Ireland ETF
RXD10.820.04
+0.33%
ProShares UltraShort Health Care
LFAX163.06N/A
N/A
LifeX 2061 Longevity Income ETF
SHE127.75-0.97
-0.75%
SPDR® MSCI USA Gender Diversity ETF
IMCB81.69-1.01
-1.22%
iShares Morningstar Mid-Cap ETF

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
-0.17%
NVST - SOLV
55%
Loosely correlated
+0.61%
BAX - SOLV
51%
Loosely correlated
+0.97%
RMD - SOLV
49%
Loosely correlated
+0.11%
AZTA - SOLV
49%
Loosely correlated
-1.72%
ALC - SOLV
46%
Loosely correlated
+1.91%
More